Inventor · disambiguated record
Robert P. Lenk
Also filed as: LENK ROBERT · LENK ROBERT P
20 granted patents·8 pending applications·1,979 citations·filing 1983–2012
97Inventor score
Files withLIPOSOME CO INC13LUNA INNOVATIONS INC5UNIV TEXAS4KEPLEY CHRISTOPHER L3MACFARLAND DARREN K1
Top patents by PatentIndex Score
28 records- 0197US5000958AEnhancement of pharmaceutical activityLIPOSOME CO INC·Filed 1984·Granted Mar 19, 1991·145 cites·52 claims
- 0297US4522803AStable plurilamellar vesicles, their preparation and useLIPOSOME CO INC·Filed 1983·Granted Jun 11, 1985·475 cites·44 claims
- 0396US5169637AStable plurilamellar vesiclesLIPOSOME CO INC·Filed 1991·Granted Dec 8, 1992·213 cites·17 claims
- 0495US5030453AStable plurilamellar vesiclesLIPOSOME CO INC·Filed 1984·Granted Jul 9, 1991·189 cites·23 claims
- 0595US4981692ATherapeutic treatment by intramammary infusionLIPOSOME CO INC·Filed 1987·Granted Jan 1, 1991·161 cites·21 claims
- 0694US5948441AMethod for size separation of particlesLIPOSOME CO INC·Filed 1995·Granted Sep 7, 1999·183 cites·12 claims
- 0794US5616334ALow toxicity drug-lipid systemsLIPOSOME CO INC·Filed 1995·Granted Apr 1, 1997·102 cites·23 claims
- 0892US5059591ADrug preparations of reduced toxicityLIPOSOME CO INC·Filed 1989·Granted Oct 22, 1991·132 cites·44 claims
- 0988US5811119AFormulation and use of carotenoids in treatment of cancerUNIV TEXAS·Filed 1996·Granted Sep 22, 1998·83 cites·2 claims
- 1086US4897384ADrug preparations of reduced toxicityLIPOSOME CO INC·Filed 1986·Granted Jan 30, 1990·79 cites·25 claims
- 1181US8241648B2Amphiphilic or lipophilic polar functionalized fullerenes and their usesZHOU ZHIGUO·Filed 2008·Granted Aug 14, 2012·5 cites·17 claims
- 1276US5366958ALocalized delivery using fibronectin conjugatesLIPOSOME CO INC·Filed 1993·Granted Nov 22, 1994·48 cites·25 claims
- 1375US5262168AProstaglandin-lipid formulationsLIPOSOME CO INC·Filed 1992·Granted Nov 16, 1993·47 cites·45 claims
- 1470US5178875ALiposomal-polyene preliposomal powder and method for its preparationUNIV TEXAS·Filed 1991·Granted Jan 12, 1993·33 cites·68 claims
- 1568US5082664AProstaglandin-lipid formulationsLIPOSOME CO INC·Filed 1988·Granted Jan 21, 1992·34 cites·51 claims
- 1664US5925375ATherapeutic use of multilamellar liposomal prostaglandin formulationsLIPOSOME CO INC·Filed 1994·Granted Jul 20, 1999·30 cites·19 claims
- 1758US6200597B1Formulation and use of carotenoids in treatment of cancerUNIV TEXAS·Filed 1998·Granted Mar 13, 2001·17 cites·6 claims
- 1858US2008214514A1Steroid derivatives of fullerenesLUNA INNOVATIONS INC·Filed 2008·Application pending·0 cites
- 1956US2011009486A1Method for treating pruritus by administering fullerenesLUNA INNOVATIONS INC·Filed 2009·Application pending·0 cites
- 2054US9233177B2Metallofullerene contrast agentsMACFARLAND DARREN K·Filed 2008·Granted Jan 12, 2016·0 cites·9 claims
- 2150US2011190251A1Method for inhibiting the build-up of arterial plaque by administering fullerenesKEPLEY CHRISTOPHER L·Filed 2009·Application pending·0 cites
- 2248US8680125B2Fullerene therapies for inflammationKEPLEY CHRISTOPHER L·Filed 2009·Granted Mar 25, 2014·0 cites·3 claims
- 2341US2011003773A1Using fullerenes to enhance and stimulate hair growthLUNA INNOVATIONS INC·Filed 2009·Application pending·0 cites
- 2438US2011021630A1Method for treating wounds by administering fullerenesKEPLEY CHRISTOPHER L·Filed 2009·Application pending·0 cites
- 2537US2002119170A1Low toxicity drug-lipid systemsFiled 2002·Application pending·0 cites
- 2636US5830498ALiposomal-polyene preliposomal powder and method for its preparationUNIV TEXAS·Filed 1995·Granted Nov 3, 1998·3 cites·4 claims
- 2736US2014161733A1Biomarker-targeting contrast agents and their use in magnetic resonance imaging for detection of atherosclerotic plaqueLUNA INNOVATIONS INC·Filed 2012·Application pending·0 cites
- 2831US2011251158A1Fullerene therapies for inflammation and inhibition of build-up of arterial plaqueLUNA INNOVATIONS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert P. Lenk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →